✦ LIBER ✦

683 Randomised, double-blind, active-controlled phase III study to assess the long-term safety and efficacy of mirabegron in overactive bladder (OAB)

✍ Scribed by C.R. Chapple; S. Kaplan; H.D. Mitcheson; J. Klecka; J. Cummings; T. Drogendijk; C. Dorrepaal; N.E. Martin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Double-blind, Active-controll

✍ Christopher R. Chapple; Steven A. Kaplan; David Mitcheson; Jiri Klecka; Jana Cum 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 508 KB

A Phase III, Randomized, Double-blind, P

✍ Herschorn, Sender; Barkin, Jack; Castro-Diaz, David; Frankel, Jeffrey M.; Espuna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 407 KB

A randomized double-blind placebo-contro

✍ Dudley Robinson; Linda Cardozo; Gerben Terpstra; John Bolodeoku; the Tamsulosin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL

✍ Rabinowitz, Jonathan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Study to compare the efficacy and safety

✍ S. M. Yim; J. H. Ko; Y. W. Lee; H. W. Kim; J. Y. Lee; N. I. Kim; Y. C. Kye; K. C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

A randomised, placebo-controlled, double

✍ Marco Cicardi; Roberto Perricone; Mauro Cancian; Vincenzo Montinaro; Enrico Cill 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB